Copyright Reports & Markets. All rights reserved.

Biotextiles Global Market

Buy now

1 EXECUTIVE SUMMARY 19

    2 INTRODUCTION 24

    • 2.1 KEY TAKEAWAYS 24
    • 2.2 REPORT DESCRIPTION 25
    • 2.3 MARKETS COVERED 27
    • 2.4 STAKEHOLDERS 28
    • 2.5 RESEARCH METHODOLOGY 29
      • 2.5.1 MARKET SIZE ESTIMATION 30
      • 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 33
      • 2.5.3 SECONDARY SOURCES 34
      • 2.5.4 PRIMARY SOURCES 35
      • 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 35
      • 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 36
      • 2.5.7 ASSUMPTIONS 37

    3 MARKET ANALYSIS 38

    • 3.1 INTRODUCTION 38
    • 3.2 MARKET SEGMENTATION 39
    • 3.3 FACTORS INFLUENCING MARKET 41
      • 3.3.1 DRIVERS AND OPPORTUNITIES 42
        • 3.3.1.1 Increasing aging population 42
        • 3.3.1.2 Increasing minimally invasive surgery 42
        • 3.3.1.3 Increase in accidents and sports injuries 43
        • 3.3.1.4 Technological advancements in fibres and fabrication methods 43
        • 3.3.1.5 Increasing prevalence of life style diseases 44
        • 3.3.1.6 Increase in cardiovascular diseases and heart failure 45
        • 3.3.1.7 Demand for orthopedic implants 45
        • 3.3.1.8 Growth in emerging countries 46
        • 3.3.1.9 Growing healthcare budgetary allocation 47
      • 3.3.2 RESTRAINTS AND THREATS 47
        • 3.3.2.1 Limitations of biotextiles based products 47
        • 3.3.2.2 Lack of skilled and trained professionals 48
        • 3.3.2.3 Stringent regulatory processes for approval 49
        • 3.3.2.4 Reimbursement issues in emerging countries 49
    • 3.4 REGULATORY AFFAIRS 50
      • 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 50
        • 3.4.1.1 ISO 9001: 2015 quality management system 50
        • 3.4.1.2 ISO 13485 medical devices 50
        • 3.4.1.3 ISO 10993 biological evaluation of medical devices 51
        • 3.4.1.4 ISO 14644-1 clean room standards 51
      • 3.4.2 ASTM INTERNATIONAL STANDARDS 51
      • 3.4.3 U.S. 52
      • 3.4.4 CANADA 53
      • 3.4.5 EUROPE 53
      • 3.4.6 JAPAN 54
      • 3.4.7 CHINA 55
      • 3.4.8 INDIA 55
    • 3.5 PORTER’S FIVE FORCE ANALYSIS 57
      • 3.5.1 THREAT OF NEW ENTRANTS 58
      • 3.5.2 THREAT OF SUBSTITUTES 58
      • 3.5.3 BARGAINING POWER OF SUPPLIERS 59
      • 3.5.4 BARGAINING POWER OF BUYERS 59
      • 3.5.5 RIVALRY AMONG EXISTING COMPETITORS 60
    • 3.6 SUPPLY CHAIN ANALYSIS 60
    • 3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 64
    • 3.8 MATRIX OF BIOTEXTILES TYPE AND APPLICATIONS 67
    • 3.9 BIOTEXTILES COMPANY COMPARISON TABLE BY TEXTILE TYPES, APPLICATIONS AND MATERIALS 67

    4 BIOTEXTILES GLOBAL MARKET, BY MANUFACTURING TECHNIQUE 77

    • 4.1 INTRODUCTION 77
    • 4.2 WOVEN TEXTILES 80
    • 4.3 NON-WOVEN TEXTILES 83
    • 4.4 BRAIDED TEXTILES 86
    • 4.5 KNITTED TEXTILES 89

    5 BIOTEXTILES GLOBAL MARKET, BY MATERIAL 92

    • 5.1 INTRODUCTION 92
    • 5.2 NON-BIOABSORBABLE 95
    • 5.3 BIOABSORBABLE 98

    6 BIOTEXTILES GLOBAL MARKET, BY APPLICATION 101

    • 6.1 INTRODUCTION 101
    • 6.2 CARDIOVASCULAR 104
      • 6.2.1 STENTS 109
      • 6.2.2 STENT GRAFTS 111
      • 6.2.3 HEART VALVE REPLACEMENT 113
      • 6.2.4 HEART VALVE REPAIR 115
      • 6.2.5 OTHERS 117
    • 6.3 ORTHOPAEDIC 119
      • 6.3.1 ARTIFICIAL LIGAMENTS AND TENDONS 124
      • 6.3.2 SUTURES AND SUTURE ANCHORS 126
      • 6.3.3 OTHERS 128
    • 6.4 GYNAECOLOGY AND UROLOGY 129
      • 6.4.1 INCONTINENCE SLINGS 133
      • 6.4.2 PELVIC FLOOR REPAIR MESH 135
      • 6.4.3 OTHERS 137
    • 6.5 GENERAL SURGERY 138
      • 6.5.1 SUTURES 142
      • 6.5.2 HERNIA REPAIR MESH 144
      • 6.5.3 COSMETIC SURGERY 146
      • 6.5.4 OTHERS 147
    • 6.6 OTHER APPLICATIONS 149

    7 REGIONAL ANALYSIS 152

    • 7.1 INTRODUCTION 152
    • 7.2 NORTH AMERICA 155
      • 7.2.1 U.S. 165
      • 7.2.2 OTHERS 167
    • 7.3 EUROPE 169
      • 7.3.1 GERMANY 179
      • 7.3.2 U.K. 181
      • 7.3.3 FRANCE 183
      • 7.3.4 OTHERS 185
    • 7.4 APAC 187
      • 7.4.1 JAPAN 197
      • 7.4.2 CHINA 199
      • 7.4.3 INDIA 201
      • 7.4.4 OTHERS 203
    • 7.5 ROW 205
      • 7.5.1 BRAZIL 214
      • 7.5.2 REST OF LATIN AMERICA 216
      • 7.5.3 MIDDLE EAST AND OTHERS 218

    8 COMPETITIVE LANDSCAPE 220

    • 8.1 INTRODUCTION 220

    9 MAJOR COMPANIES 230

    • 9.1 ATEX TECHNOLOGIES, INC. 230
      • 9.1.1 OVERVIEW 230
      • 9.1.2 FINANCIALS 230
      • 9.1.3 PRODUCT PORTFOLIO 231
      • 9.1.4 KEY DEVELOPMENTS 231
      • 9.1.5 BUSINESS STRATEGY 231
      • 9.1.6 SWOT ANALYSIS 232
    • 9.2 C.R.BARD 233
      • 9.2.1 OVERVIEW 233
      • 9.2.2 FINANCIALS 234
      • 9.2.3 PRODUCT PORTFOLIO 237
      • 9.2.4 KEY DEVELOPMENTS 237
      • 9.2.5 BUSINESS STRATEGY 237
      • 9.2.6 SWOT ANALYSIS 238
    • 9.3 CONFLUENT MEDICAL TECHNOLOGIES 239
      • 9.3.1 OVERVIEW 239
      • 9.3.2 FINANCIALS 239
      • 9.3.3 PRODUCT PORTFOLIO 240
      • 9.3.4 KEY DEVELOPMENTS 240
      • 9.3.5 BUSINESS STRATEGY 241
      • 9.3.6 SWOT ANALYSIS 242
    • 9.4 FENNER PLC (SECANT GROUP LLC) 243
      • 9.4.1 OVERVIEW 243
      • 9.4.2 FINANCIALS 244
      • 9.4.3 PRODUCT PORTFOLIO 247
      • 9.4.4 KEY DEVELOPMENTS 248
      • 9.4.5 BUSINESS STRATEGY 249
      • 9.4.6 SWOT ANALYSIS 250
    • 9.5 GETINGE GROUP (MAQUET) 251
      • 9.5.1 OVERVIEW 251
      • 9.5.2 FINANCIALS 252
      • 9.5.3 PRODUCT PORTFOLIO 254
      • 9.5.4 KEY DEVELOPMENTS 254
      • 9.5.5 BUSINESS STRATEGY 255
      • 9.5.6 SWOT ANALYSIS 256
    • 9.6 MEDTRONIC PLC 257
      • 9.6.1 OVERVIEW 257
      • 9.6.2 FINANCIALS 258
      • 9.6.3 PRODUCT PORTFOLIO 260
      • 9.6.4 KEY DEVELOPMENTS 261
      • 9.6.5 BUSINESS STRATEGY 263
      • 9.6.6 SWOT ANALYSIS 264
    • 9.7 RUA MEDICAL 265
      • 9.7.1 OVERVIEW 265
      • 9.7.2 FINANCIALS 265
      • 9.7.3 PRODUCT PORTFOLIO 266
      • 9.7.4 KEY DEVELOPMENTS 267
      • 9.7.5 BUSINESS STRATEGY 267
      • 9.7.6 SWOT ANALYSIS 268
    • 9.8 TERUMO CORPORATION (VASCUTEK LTD.) 269
      • 9.8.1 OVERVIEW 269
      • 9.8.2 FINANCIALS 270
      • 9.8.3 PRODUCT PORTFOLIO 272
      • 9.8.4 KEY DEVELOPMENTS 273
      • 9.8.5 BUSINESS STRATEGY 273
      • 9.8.6 SWOT ANALYSIS 274
    • 9.9 US BIODESIGN, LLC 275
      • 9.9.1 OVERVIEW 275
      • 9.9.2 FINANCIALS 275
      • 9.9.3 PRODUCT PORTFOLIO 276
      • 9.9.4 KEY DEVELOPMENTS 276
      • 9.9.5 BUSINESS STRATEGY 276
      • 9.9.6 SWOT ANALYSIS 277
    • 9.10 W.L.GORE & ASSOCIATES, INC. 278
      • 9.10.1 OVERVIEW 278
      • 9.10.2 FINANCIALS 278
      • 9.10.3 PRODUCT PORTFOLIO 279
      • 9.10.4 KEY DEVELOPMENTS 279
      • 9.10.5 BUSINESS STRATEGY 282

    Biomedical textiles are one of the fastest growing fields in technical textile industry. Biomedical textiles can be categorized into two types i.e. Medical textiles and Biotextiles. Medical textiles market include products such as wound dressing, bandages, surgical dressing, medical clothing, barrier fabrics, protective clothing, surgical masks, sterile scrubs, etc. The BioTextiles are the textiles composed of synthetic or natural fibres designed specifically for implant procedures where there performance depends on biocompatibility and biostability with tissue and biological fluids. BioTextiles are used as implantable fabrics or as components of implantable devices. BioTextiles are used in applications such as surgical mesh, stent grafts, surgical sutures, hernia repair fabrics, artificial skin, heart patch, heart valves, artificial tendons & ligaments, cosmetic surgery, tissue engineering, neurovascular conduits, etc.
    This report concentrates on biotextiles that are used as implants or components of implantable devices. The non-implant textiles or devices are not considered in biotextiles global market report.
    The biotextiles market is classified based on manufacturing techniques, materials, applications and geography. By manufacturing technique, the market is segmented into woven textiles, non-woven textiles, braided textiles and knitted textiles. By materials, the market is segmented into Non-bioabsorbable textiles and Bioabsorbable textiles. By application, biotextiles market is segmented into cardiovascular, orthopedic, gynaecology & urology, general surgery and other applications.
    The BioTextiles global market is expected to grow at mid single digit CAGR to reach $7,390.4 million by 2023. Among the Biotextiles product by manufacturing technique, the braided textiles segment dominates the market by occupying a largest share and woven textiles segment is the fastest growing market from 2016 to 2023. In the BioTextiles applications, General surgery held XX% share in 2016 expected to grow at a CAGR of X% to reach $XX million by 2023. Cardiovascular segment is the fastest growing market with a strong CAGR of X% from 2016 to 2023.
    The Biotextiles global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue of $XX million in 2016 and expected to reach $XX million by 2023 at a CAGR of X%. A high prevalence of cardiovascular diseases (such as heart failure, cardiogenic shock, dilated cardiomyopathy, ventricular insufficiency, Valvular heart disease, and congenital heart diseases), orthopaedic disorders, increase in minimally invasive surgeries, cosmetic surgeries, growth in aging population and shortage of heart donor organs led the market growth in this region. However, Asia-Pacific is expected to grow at a CAGR of X% to reach $XX million by 2023 owing to the rapidly increasing aging population with high prevalence of cardiovascular diseases, orthopaedic diseases, improving healthcare infrastructure and rise in healthcare spending in the emerging countries, such as India and China.
    The BioTextiles market is a highly fragmented market. Major players in BioTextiles market include ATEX Technologies, Inc. (U.S.), C.R.Bard, Inc. (U.S.), Confluent Medical Technologies (U.S.), Culzean Textile Solutions Ltd. (U.K.), Getinge Group (Maquet) (Sweden), J-Pac Medical (U.S.), Medtronic PLC (Ireland), Poly-Med, Inc. (U.S.), RUA Medical (U.K.), Terumo Corporation (vascutek) (Japan), U.S. Biodesign (U.S.), W.L. Gore & Associates Inc. (U.S.).
    The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
    • North America
    o U.S.
    o Others
    • Europe
    o Germany
    o U.K.
    o France
    o Others
    • Asia-Pacific
    o Japan
    o China
    o India
    o Others
    • Rest of the World (RoW)
    o Brazil
    o Rest of Latin America
    o Middle East & Others

    Buy now